Chao Ma
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in ⓘ
-
- RNA modifications and cancer 21
- Epigenetics and DNA Methylation 6
-
- Cancer-related molecular mechanisms research 19
- Co-authors
- Huan Luo (16 shared papers)Jing Cao (6 shared papers)Jinpo Yang (2 shared papers)Feng Li (1 shared paper)Lei Fan (3 shared papers)Qian Wang (2 shared papers)Huaiyin Shi (2 shared papers)Lu Sun (2 shared papers)
- Journals
- Scientific Reports (4 papers)Frontiers in Cell and Developmental Biology (2 papers)Oncology Reports (2 papers)BioMed Research International (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Chao Ma
80 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Cancer Research 473
- Molecular Biology 620
- Oncology 234
- Pulmonary and Respiratory Medicine 269
- Immunology 167
Countries citing papers authored by Chao Ma
This map shows the geographic impact of Chao Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Ma more than expected).
Fields of papers citing papers by Chao Ma
This network shows the impact of papers produced by Chao Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Ma. The network helps show where Chao Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Chao Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 71 | |
| 2 | 2021 | 61 | |
| 3 | 2017 | 54 | |
| 4 | 2020 | 50 | |
| 5 | 2021 | 49 | |
| 6 | MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells. | 2015 | 48 |
| 7 | 2015 | 42 | |
| 8 | 2016 | 38 | |
| 9 | 2015 | 38 | |
| 10 | 2017 | 38 | |
| 11 | 2020 | 37 | |
| 12 | 2020 | 36 | |
| 13 | 2020 | 33 | |
| 14 | 2019 | 33 | |
| 15 | Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma. | 2014 | 29 |
| 16 | 2020 | 25 | |
| 17 | 2016 | 24 | |
| 18 | 2021 | 23 | |
| 19 | 2021 | 22 | |
| 20 | 2018 | 21 |
About Chao Ma
Chao Ma is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 91 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (21 papers), Cancer-related molecular mechanisms research (19 papers), Ferroptosis and cancer prognosis (16 papers), Myasthenia Gravis and Thymoma (9 papers), Epigenetics and DNA Methylation (6 papers), Glioma Diagnosis and Treatment (6 papers), Thyroid and Parathyroid Surgery (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (473 citations), Molecular Biology (620 citations), Oncology (234 citations), Pulmonary and Respiratory Medicine (269 citations) and Immunology (167 citations). Chao Ma has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Huan Luo, Jing Cao, Jinpo Yang, Feng Li, Lei Fan, Qian Wang, Huaiyin Shi, Lu Sun, Lixin Wei and Yanmin Zhang. Their work appears in journals such as Scientific Reports, Frontiers in Cell and Developmental Biology, Oncology Reports, BioMed Research International and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.